Type I interferon signaling controls the early hematopoietic expansion in response to β-glucan
Rapid hematopoietic adaptations are important for building and sustaining the biological response to β-glucan. The signals involved in these early events have not yet been fully explored. Given that type I interferons are produced in response to β-glucan and can profoundly impact hematopoietic stem cell (HSC) function, we hypothesized that this pathway may be involved in the early bone marrow response to β-glucan. <i>In vivo</i> administration of β-glucan led to local interferon-α production in the peritoneal cavity and bone marrow, upregulation of its receptor, IFNAR1, specifically on long-term hematopoietic stem cells (LT-HSCs), and broad expansion of downstream progenitor subpopulations. We demonstrate that intact type I interferon signaling is critical for β-glucan-mediated LT-HSC proliferation, mitochondrial activity, and glycolytic commitment. By determining that type I interferon signaling is important for LT-HSCs, which sit at the apex of the hematopoietic hierarchy, we uncover an important component of the early inflammatory response to β-glucan.
Authors
- Yangsong Xu (ORCID: https://orcid.org/0000-0003-2901-7642)
- Paul J. Hertzog (ORCID: https://orcid.org/0000-0002-1373-8472)
- Andrew J. Fleetwood (ORCID: https://orcid.org/0000-0002-6803-3533)
- Nicole A. de Weerd (ORCID: https://orcid.org/0000-0002-7985-189X)
- Dragana Dragoljevic
- Man K.S. Lee
- Andrew James Murphy (ORCID: https://orcid.org/0000-0001-7039-7777)
- Dmitri Sviridov (ORCID: https://orcid.org/0000-0002-5595-0455)
- Camilla Bertuzzo Veiga (ORCID: https://orcid.org/0000-0001-6989-9374)
- Ziyue Fu (ORCID: https://orcid.org/0009-0004-0785-871X)
Institutions
- Baker Heart and Diabetes Institute (AU)
- Hudson Institute of Medical Research (AU)
- Monash University (AU)
Publication Details
- Journal
- iScience
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1016/j.isci.2025.112347
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Diabetes Victoria
- National Institutes of Health
- National Health and Medical Research Council